Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07JWO
|
||||
| Former ID |
DNCL002312
|
||||
| Drug Name |
IL-21
|
||||
| Synonyms |
BMS-982470
|
||||
| Company |
Bristol-Myers Squibb
|
||||
| Target and Pathway | |||||
| Target(s) | IL-21 | Target Info | Modulator | [550398] | |
| PANTHER Pathway | Interleukin signaling pathway | ||||
| WikiPathways | Allograft Rejection | ||||
| References | |||||
| Ref 468116 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4987). | ||||
| Ref 523093 | ClinicalTrials.gov (NCT01152788) Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.